We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Heron Therapeutics announced increased net product sales ...
Duarte reaffirmed, "We are reaffirming our previously given guidance for net revenue of $153 million to $163 million and adjusted EBITDA of $9 million to $13 million." Hensley emphasized expected ...
CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results